The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| AMARIN CORP PLC | SPONS ADR NEW | 023111206 | 1,805 | 450,000 | SH | SOLE | 450,000 | 0 | 0 | ||
| APRICUS BIOSCIENCES INC | COM NEW | 03832V307 | 184 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
| FIBROCELL SCIENCE INC | COM PAR | 315721308 | 6 | 10,000 | SH | Call | SOLE | 10,000 | 0 | 0 | |
| FLUIDIGM CORP DEL | COM | 34385P108 | 2,418 | 410,500 | SH | SOLE | 410,500 | 0 | 0 | ||
| GILEAD SCIENCES INC | COM | 375558103 | 4,298 | 60,000 | SH | Call | SOLE | 60,000 | 0 | 0 | |
| GILEAD SCIENCES INC | COM | 375558103 | 5,373 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
| GLAXOSMITHKLINE PLC | SPONSORED ADR | 37733W105 | 1,774 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
| MANNKIND CORP | COM NEW | 56400P706 | 116 | 50,000 | SH | Put | SOLE | 50,000 | 0 | 0 | |
| NOVELION THERAPEUTICS INC | COM NEW | 67001K202 | 3,120 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | ||
| PROSHARES TR | ULTSH NASD BIOT | 74347B789 | 551 | 25,000 | SH | SOLE | 25,000 | 0 | 0 | ||
| TYME TECHNOLOGIES INC | COM | 90238J103 | 13,239 | 2,075,000 | SH | SOLE | 2,075,000 | 0 | 0 | ||